Targeting Recalcitrant Pathogens with Precision Medicine As we enter 2026, the scientific community is shifting away from broad spectrum antibiotics in favor of precision-guided antibacterial drugs. This transition is driven by the urgent need for antibiotic resistance management in clinical settings where traditional therapies have failed. Researchers are now utilizing CRISPR-based delivery...

Executive Summary Cardiopulmonary Exercise Testing Market Size and Share Analysis Report The global cardiopulmonary exercise testing market size was valued at USD 3.82 billion in 2024 and is expected to reach USD 5.26 billion by 2032, at a CAGR of 4.10% during the forecast period. This Cardiopulmonary Exercise Testing Market report is useful in...